The Future of Managed Care and PAH?
In this AJMCtv video from the American Journal of Managed Care, Dr. Derek Van Amerongen, vice president of Humana Ohio, explains the role of managed care companies in regard to chronic rare diseases such as pulmonary arterial hypertension (PAH).
Amerongen acknowledges that managed care needs to maximize treatment and “improve and expand access to therapies.” He also talks about the importance of PAH clinical trials and how managed care could support trials and patients who need them most.
Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.